Xtant Medical Highlights Growing Product Portfolio at NASS 2023

Rhea-AI Summary

Xtant Medical Holdings to exhibit orthobiologics and spinal fixation products at NASS 2023 Annual Meeting

Positive

• Xtant Medical Holdings will showcase its suite of orthobiologics and spinal fixation products at the NASS 2023 Annual Meeting.
• The company has expanded its product portfolio in recent years, including the popular OsteoFactor and OsteoVive Plus products and the newly added Coflex and CoFix products.

Negative

• None.

BELGRADE, Mont., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it will exhibit its suite of orthobiologics and spinal fixation products at the North American Spine Society (NASS) 2023 Annual Meeting, which will be held October 18-21 at the Los Angeles Convention Center in Los Angeles, CA.

“In recent years, we have dramatically expanded our product portfolio, most notably with the introductions of the highly popular OsteoFactor and OsteoVive Plus products and the newly added Coflex and CoFix products,” said Sean Browne, Chief Executive Officer of Xtant Medical. “Spinal surgeons and physicians recognize the critical patient benefits from our complementary biologics and fixation product offerings. We are proud that Xtant remains at the forefront of innovative spinal solutions, and look forward to showcasing our deep portfolio at NASS.”

Physicians, surgeons and members of the financial community interested in learning more about Xtant’s products can visit Xtant’s Booth #1603 or contact Marketing@xtantmedical.com.

About the North American Spine Society

NASS a global multidisciplinary medical organization dedicated to fostering the highest quality, ethical, value-based and evidenced-based spine care by promoting education, research and advocacy. NASS is comprised of more than 8,000 members from several disciplines, including orthopedic surgery, neurosurgery, physiatry, neurology, radiology, anesthesiology, research and physical therapy. For more information, visit www.spine.org, NASS’ Facebook, Twitter, Instagram and LinkedIn channels.

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact

David Carey
FINN Partners
Ph: 212-867-1762
Email: david.carey@finnpartners.com

FAQ

What is Xtant Medical Holdings?

Xtant Medical Holdings is a global medical technology company focused on surgical solutions for spinal disorders.

What products will Xtant Medical exhibit at the NASS 2023 Annual Meeting?

Xtant Medical will showcase its suite of orthobiologics and spinal fixation products.

Where will the NASS 2023 Annual Meeting be held?

The NASS 2023 Annual Meeting will be held at the Los Angeles Convention Center in Los Angeles, CA.

What are some of Xtant Medical's recently introduced products?

Xtant Medical has recently introduced the OsteoFactor, OsteoVive Plus, Coflex, and CoFix products.

How can I learn more about Xtant's products?

Physicians, surgeons, and members of the financial community can visit Xtant's Booth #1603 at the NASS 2023 Annual Meeting or contact Marketing@xtantmedical.com.